Ms. Na Meng has over a decade of experience in strategy and capital markets within the healthcare sector. She started her career at Bank of America Merrill Lynch and Deutsche Bank in Hong Kong, covering the Asia-Pacific healthcare sector. She has since led corporate strategy, capital markets, and investor relations at I-Mab and Genorbio, where she successfully executed a number of landmark transactions including IPOs, spin-offs, and strategic partnerships. Ms. Meng earned a Master in Management from HEC Paris and a Bachelor’s degree from Fudan University, and is a Chartered Financial Analyst.